GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » TFBS Bioscience Inc (ROCO:6939) » Definitions » Market Cap

TFBS Bioscience (ROCO:6939) Market Cap : NT$1,269.4 Mil (As of Dec. 14, 2024)


View and export this data going back to 2023. Start your Free Trial

What is TFBS Bioscience Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). TFBS Bioscience's share price for the quarter that ended in Jun. 2024 was NT$41.2. TFBS Bioscience's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 34.9 Mil. Therefore, TFBS Bioscience's market cap for the quarter that ended in Jun. 2024 was NT$1,438.8 Mil.

TFBS Bioscience's quarterly market cap declined from Jun. 2023 (NT$2,208.2 Mil) to Dec. 2023 (NT$1,586.7 Mil) and declined from Dec. 2023 (NT$1,586.7 Mil) to Jun. 2024 (NT$1,438.8 Mil).

TFBS Bioscience's annual market cap stayed the same from Dec. 2021 (NT$0.0 Mil) to Dec. 2022 (NT$0.0 Mil) but then increased from Dec. 2022 (NT$0.0 Mil) to Dec. 2023 (NT$1,586.7 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. TFBS Bioscience's Enterprise Value for Today is NT$603.1 Mil.


TFBS Bioscience Market Cap Historical Data

The historical data trend for TFBS Bioscience's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TFBS Bioscience Market Cap Chart

TFBS Bioscience Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Market Cap
- - - 1,586.66

TFBS Bioscience Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Market Cap Get a 7-Day Free Trial - - 2,208.16 1,586.66 1,438.79

Competitive Comparison of TFBS Bioscience's Market Cap

For the Diagnostics & Research subindustry, TFBS Bioscience's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TFBS Bioscience's Market Cap Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, TFBS Bioscience's Market Cap distribution charts can be found below:

* The bar in red indicates where TFBS Bioscience's Market Cap falls into.



TFBS Bioscience Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

TFBS Bioscience's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=NT$45.6*34.7952
=NT$1,586.7

TFBS Bioscience's Market Cap for the quarter that ended in Jun. 2024 is calculated as

Market Cap (Q: Jun. 2024 )=Share Price (Q: Jun. 2024 )*Shares Outstanding (EOP) (Q: Jun. 2024 )
=NT$41.2*34.922
=NT$1,438.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TFBS Bioscience  (ROCO:6939) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


TFBS Bioscience Market Cap Related Terms

Thank you for viewing the detailed overview of TFBS Bioscience's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


TFBS Bioscience Business Description

Traded in Other Exchanges
N/A
Address
No. 103, Lane 169, Kang-ning Street, 3rd Floor, Xizhi District, New Taipei, TWN
TFBS Bioscience Inc is a Contract Research Organization (CRO) providing biological testing in Taiwan. Its services include viral vector manufacturing for cell and gene therapy products and biosafety testing and product release testing for cell and gene therapy products, vaccines, and biologic products.

TFBS Bioscience Headlines

No Headlines